Novel Communications in Diabetes:: Another Small but Significant Step for Diabetes Care

• Autores: William T. Cefalu
• Localización: Diabetes care, ISSN-e 0149-5992, Vol. 36, Nº. 4, 2013, págs. 773-774
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • In my commentary �Diabetes Care: �State of the Union�� that appeared in the January 2013 issue of Diabetes Care, I gave a comprehensive listing of the progress made to date for the first year for our current editorial team (1). At that time, and also at the beginning of our term over a year ago, I continued to stress that our goal as an editorial team was to adhere to �a strategy to continue the momentum and make changes only as required to allow the journal to thrive� (1,2). With this commentary, I wanted to inform our readers, authors, and reviewers that we have taken yet another small but significant step toward that goal. In brief, these steps involve the elimination of one manuscript category (Brief Report), the introduction of a new category for author consideration and submission (Novel Communications in Diabetes), and the addition of a former manuscript interest area (Emerging Technologies and Therapeutics).

    To understand why we are implementing these changes, one has to look no further than what has happened to the diabetes landscape over the last few years. There is no question that there are tremendous advancements in clinical care, clinical research, and translation of findings. We have and will continue to readily review and publish the top articles in these areas and, in many cases, actively seek and request submission of the truly unique manuscripts to our journal. Clearly, the incredible changes occurring in technology cannot be overstated. It is truly amazing how things have changed in the way we now obtain information from scientific journals in general, and this �